Winter 2012

January February 2012 Insert

Articles

Peer Review

Clinical Strategies

  • Optic Disc Drusen

    Practical implications and management.

    By Tomas M. Grippo, MD; Spencer W. Rogers, MD; James C. Tsai, MD, MBA; and Richard A. Lewis, MD

Challenging Cases

Cover Stories:
Changing Paradigms in Glaucoma Education

Inside Eyetube.net

View All News >
News
FDA Turns Down Merck’s Glaucoma Drug

Merck and Co., Inc. (Whitehouse Station, NJ), received a complete response letter from the FDA turning down the company’s application for the glaucoma drug tafluprost. Data were presented for the first time on tafluprost at... more >

News
OptiMedica Receives FDA Market Clearance of the Catalys Precision Laser System

OptiMedica Corporation (Santa Clara, CA) announced that it has received FDA 510(k) market clearance for its Catalys Precision Laser System. The system is cleared for the creation of the capsulotomy and/or lens fragmentation. ... more >

News
pSivida Announces Technology Evaluation Agreement With Pharmaceutical Company

In a news release, pSivida Corp. (Perth, Western Australia) announced that it has signed a funded technology evaluation agreement with a leading global pharmaceutical company to assess Durasert— pSivida’s bioerodible implan... more >

TOP 5 ARTICLES FROM FEBRUARY 2012